Tag: OSL

OncoSil Medical breakthrough device treatment pancreatic cancer CE Marking approval ASX OSL

OncoSil Medical obtains CE Mark and breakthrough device designation for its pancreatic tumour isotope

Medical device company OncoSil Medical (ASX: OSL) has announced that it has finally received the CE Mark from the British Standards Institute (BSI) for its proprietary OncoSil device – a means of trea...
OncoSil unresectable pancreatic cancer treatment FDA ASX OSL breakthrough device designation

FDA grants breakthrough device designation for OncoSil

Medical device company OncoSil Medical (ASX: OSL) has been granted what’s known as breakthrough device designation by the US Food and Drug Administration (FDA) for the treatment of pancreatic cancer i...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS